Petmed Express Stock Net Income
PETS Stock | USD 4.76 0.02 0.42% |
PetMed Express fundamentals help investors to digest information that contributes to PetMed Express' financial success or failures. It also enables traders to predict the movement of PetMed Stock. The fundamental analysis module provides a way to measure PetMed Express' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PetMed Express stock.
Last Reported | Projected for Next Year | ||
Net Loss | -7.5 M | -7.1 M | |
Net Income Applicable To Common Shares | 267.9 K | 254.6 K | |
Net Loss | -7.5 M | -7.1 M | |
Net Loss | (0.37) | (0.35) | |
Net Income Per E B T | 1.19 | 0.76 |
PetMed | Net Income |
PetMed Express Company Net Income Analysis
PetMed Express' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current PetMed Express Net Income | (7.46 M) |
Most of PetMed Express' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PetMed Express is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PetMed Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PetMed Express is extremely important. It helps to project a fair market value of PetMed Stock properly, considering its historical fundamentals such as Net Income. Since PetMed Express' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PetMed Express' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PetMed Express' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
PetMed Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PetMed Express reported net income of (7.46 Million). This is 102.19% lower than that of the Specialty Retail sector and significantly lower than that of the Consumer Discretionary industry. The net income for all United States stocks is 101.31% higher than that of the company.
PetMed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PetMed Express' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics of similar companies.PetMed Express is currently under evaluation in net income category among its peers.
PetMed Express ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PetMed Express' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PetMed Express' managers, analysts, and investors.Environmental | Governance | Social |
PetMed Express Institutional Holders
Institutional Holdings refers to the ownership stake in PetMed Express that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of PetMed Express' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PetMed Express' value.Shares | Millennium Management Llc | 2024-06-30 | 316.1 K | Metavasi Capital Lp | 2024-09-30 | 229.1 K | Geode Capital Management, Llc | 2024-09-30 | 221.2 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 212.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 205.6 K | Two Sigma Advisers, Llc | 2024-06-30 | 183.2 K | Ameriprise Financial Inc | 2024-06-30 | 176.1 K | Invenomic Capital Management, Lp | 2024-09-30 | 172.7 K | Susquehanna International Group, Llp | 2024-06-30 | 157.7 K | Renaissance Technologies Corp | 2024-09-30 | 1.3 M | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 1.1 M |
PetMed Fundamentals
Return On Equity | -0.0092 | ||||
Return On Asset | -9.0E-4 | ||||
Profit Margin | (0) % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 47.95 M | ||||
Shares Outstanding | 20.66 M | ||||
Shares Owned By Insiders | 8.10 % | ||||
Shares Owned By Institutions | 47.86 % | ||||
Number Of Shares Shorted | 1.7 M | ||||
Price To Earning | 12.75 X | ||||
Price To Book | 1.02 X | ||||
Price To Sales | 0.38 X | ||||
Revenue | 281.06 M | ||||
Gross Profit | 78.08 M | ||||
EBITDA | (394 K) | ||||
Net Income | (7.46 M) | ||||
Cash And Equivalents | 105.41 M | ||||
Cash Per Share | 5.21 X | ||||
Total Debt | 1.45 M | ||||
Current Ratio | 5.61 X | ||||
Book Value Per Share | 4.67 X | ||||
Cash Flow From Operations | 4.32 M | ||||
Short Ratio | 9.34 X | ||||
Earnings Per Share | (0.06) X | ||||
Price To Earnings To Growth | 2.58 X | ||||
Target Price | 3.75 | ||||
Number Of Employees | 287 | ||||
Beta | 0.68 | ||||
Market Capitalization | 98.77 M | ||||
Total Asset | 169.88 M | ||||
Retained Earnings | 71.56 M | ||||
Working Capital | 21.49 M | ||||
Current Asset | 67.63 M | ||||
Current Liabilities | 7.08 M | ||||
Five Year Return | 3.99 % | ||||
Net Asset | 169.88 M | ||||
Last Dividend Paid | 0.3 |
About PetMed Express Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PetMed Express's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.